Efficacy and Adverse Reactions of Microwave Ablation for Non-Small Cell Lung Cancer#br#

doi:10.13438/j.cnki.jdzk.2025.05.010

Abstract

Abstract: Through a search of Chinese and English databases,publicly published articles in domestic and international journals on microwave ablation for the treatment of non-small cell lung cancer were identified.A total of 19 articles were included.A Meta-analysis was conducted to evaluate the efficacy and adverse reactions of microwave ablation in the treatment of non-small cell lung cancer as reported in these articles.Trial sequential analysis was then employed to verify the stability of the results in the literature and to calculate the sample size required for consistent results.The results indicated that,compared with radiotherapy and chemotherapy alone,microwave ablation combined with radiotherapy and chemotherapy significantly improved the complete response rate (P<0.000 01),partial response rate (P=0.01),and overall response rate (P<0.000 01) of patients,without significantly increasing the incidence of adverse reactions such as myelosuppression (P=0.13),gastrointestinal reactions (P=0.79),and pneumothorax (P=0.43).Regarding the complete response rate and overall response rate,the current research results are consistent.However,for the partial response rate,myelosuppression,gastrointestinal reactions,and pneumothorax,the current research results are inconsistent,and further verification with a larger sample size is still required.

Key words: lung cancer, microwave ablation, Meta-analysis, trial sequential analysis

REN Yuanmeng, LU Liqun, XU Jinhong, LEI Mingsheng, SHANG Xi. Efficacy and Adverse Reactions of Microwave Ablation for Non-Small Cell Lung Cancer#br#[J]. Journal of Jishou University(Natural Sciences Edition), 2025, 46(5): 69-76.

References

[1] BRAY FREDDIE,LAVERSANNE MATHIEU,SUNG HYUNA,et al.Global Cancer Statistics 2022:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA:A Cancer Journal for Clinicians,2024,74(3):229-263.
[2] 袁芳.微波消融联合化疗治疗晚期非小细胞肺癌的临床研究[D].济南：泰山医学院，2014.
[3] 张依品,连岩岩,上官子妍,等.局部微创消融治疗原发性肺癌的临床疗效的比较:一项网状Meta分析[J].癌症进展,2020,18(23):2393-2397;2412.
[4] 潘廷红,王洪鲁,肖伟,等.经皮微波热消融联合放化疗治疗周围型非小细胞肺癌效果观察[J].山东医药,2016，56(6):42-44.
[5] 陈辉,史小芳.微波消融术联合化疗治疗中晚期非小细胞肺癌的效果观察[J].当代医药论丛,2018，16(22):11-12.
[6] 邹红.CT引导下经皮微波消融治疗周围型肺癌的临床价值体会[J].临床医药文献电子杂志，2019，6（15）:86-88.
[7] 贾晓艳.CT引导下经皮微波消融治疗周围型肺癌的临床效果及价值评价[J].中外医学研究,2019,17(8):136-138.
[8] 胡媛媛,肖红兵,孙东旭,等.CT引导下经皮微波消融治疗周围型肺癌的临床研究[J].临床肺科杂志,2018，23（7）:1210-1213.
[9] 杨霞,叶欣,韩晓颖,等.微波消融联合放化疗治疗Ⅲ期周围型非小细胞肺癌的临床研究[J].中华临床医师杂志(电子版),2013，7（21）:9431-9435.
[10] 戎冬文,王慧宇,贾军梅,等.微波消融联合全身化疗治疗晚期非小细胞肺癌的疗效对血清VEGF、id1蛋白浓度的影响[J].现代生物医学进展，2017，17（36）:7151-7154.
[11] 王守忠,张萌,季方.微波消融治疗非小细胞肺癌的临床效果探究[J].当代医学,2021,27(19):1-3.
[12] 邢军,郑红霞.动脉化疗栓塞联合微波消融与静脉化疗治疗非小细胞肺癌临床疗效的对比[J].世界最新医学信息文摘,2019,19(91):41-45.
[13] 宋华勇.CT引导下经皮微波消融联合化疗治疗晚期非小细胞肺癌的临床观察[J].中国实用医药,2015,10(36):152-153.
[14] 彭寿洲.CT引导微波消融术在肺癌治疗中的应用[J].深圳中西医结合杂志,2016,26(14):121-122.
[15] 王玉璜,钱昌顺,陈仕林,等.MWA联合化疗治疗中晚期肺癌患者的近远期疗效分析[J].中国临床医学影像杂志,2021,32(10):722-725.
[16] 任守雷,朱鹏飞,孙文俏,等.经皮微波热消融疗法联合化疗对晚期非小细胞肺癌的治疗效果观察[J].山东医药,2015,55(28):96-98.
[17] 李瑞东,乔柱,胡东玉,等.微波消融结合放化疗治疗中晚期肺癌及肺转移瘤的疗效观察[J].中国肿瘤临床与康复，2017，24(7):777-780.
[18] 杨荣,夏月琴,焦爱民.微波消融联合化疗治疗中晚期非小细胞肺癌的临床观察[J].中外医学研究,2020,18（34）:3-5.
[19] 胡亚军.化疗联合CT引导下经皮微波消融治疗晚期非小细胞肺癌的临床观察[D].南昌：南昌大学,2014.
[20] XU Xinglu,YE Xin,LIU Gang,et al.Targeted Percutaneous Microwave Ablation at the Pulmonary Lesion Combined with Mediastinal Radiotherapy with or Without Concurrent Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer Evaluation in a Randomized Comparison Study[J].Medical Oncology,2015,32(9):227.DOI:10.1007/s12032-015-0672-1.
[21] ZHANG Yingqing,WU Yonglei,FENG Yan,et al.A Clinical Study on Microwave Ablation in Combination with Chemotherapy in Treating Peripheral IIIB-IV Non-Small Cell Lung Cancer[J].Cancer Cancer Biotherapy & Radiopharmaceuticals,2022,37(2):141-146.
[22] ZHAO Zilin,SU Zhenmi,ZHANG Wangfeng,et al.A Randomized Study Comparing the Effectiveness of Microwave Ablation Radioimmunotherapy and Postoperative Adjuvant Chemoradiation in the Treatment of Non-Small Cell Lung Cancer[J].Official Journal of the Balkan Union of Oncology,2016,21(2):326-332.